Product Details
Company Profile

Lipoprotein-Associated Phospholipase A2 Lp-PLA2 Rapid Test Kit 5000 Tests/Day

Diagnostic Kit for Lipoprotein-Associated Phospholipase A2(Immunochromatographic assay)

【Intended use】

1,This kit is used for quantitative determination of Lp-PLA2 in human whole blood, plasma and serum.

Clinically.

2.it is mainly used to evaluate the degree of atherosclerosis inflammation and the auxiliary diagnosis of cardiovascular and cerebrovascular diseases caused by atherosclerosis.

【Test principle】

1,The Lp-PLA2 Rapid Test is a one-step chromatographic sandwich immunoassay designed for the quantitative measurement of Lp-PLA2.

2,The Lp-PLA2 antigen in the sample was first bound with the conjugated compound of fluorescent labeled Lp-PLA2 monoclonal antibody, then moved and combined with another Lp-PLA2 monoclonal antibody fixed on the nitrocellulose membrane, and the double antibody sandwich complex was formed at the detection line of the cellulose nitrate membrane.

3,The quantitative detection results were obtained by NIR-1000 dry fluoroimmunoassay analyser.

4,The kit should be stored at 4℃~30℃, out of direct sunlight. It is valid for 18 months.

【Components】

Name	Quantity	Component
Test cards	25	It is composed of fluorescent pad (coated with fluorescent labeled Lp-PLA2 monoclonal antibody), nitrocellulose membrane (coated with Lp-PLA2 monoclonal antibody and Goat anti mouse IgG antibody), absorbent paper and backing
Sample diluent	25(600μL/tube)	Phosphate buffer
ID card	1	With specific stand curve file

The components in different batches of kits cannot be used interchangeably.

【Sample requirements】

Plasma, serum and whole blood can be used as samples. The whole blood should be collected in a tube containing heparin, citrate or EDTA as the anticoagulant. If the serum procedure is used, collect blood in a tube without anticoagulant and allow clotting. Hemolyzed samples should not be used.
Venous blood was collected according to routine laboratory methods to avoid hemolysis.
It is highly recommended to use fresh samples instead of keeping the samples at room temperature for a long time. After samples were collected, the detection should be completed within 4 hours at room temperature (15℃~30℃). The whole blood sample can be stored at 2℃~8℃ for 24 hours. Plasma and serum samples can be stored at 2℃~ 8℃ for 7 days, -20℃for 30 days.
Before testing, the sample should return to room temperature (15℃~30℃). The frozen samples should be completely thawed, rewarming and mixed evenly before use. Repeated freeze-thaw cycles should be avoided.

【Reference interval】

Healthy non-pregnant adults are expected to have serum Lp-PLA2 values below 175.00ng/mL. It is strongly recommended that each laboratory should determine its own normal and abnormal values based on population.

【Interpretation of results】

This reagent is only used for auxiliary detection. If the test results are abnormal, it should be reviewed in time and judged in combination with clinical symptoms.
For samples with Lp-PLA2 concentration lower than 10.00ng/mL and higher than 900.00ng/mL, the detection results are reported as "<10.00ng/mL" and "> 900.00ng/mL", respectively.

WWHS Assay list
Cardiac
cat#.	Product item	Specimen	Reaction Time	Measure Range	Clinical Range	Itended Use
1	cTnI	WB/Serum/Plasma	12min.	0.1-40ng/ml	<0.3ng/ml	several heart diseases including myocardial infarction and heart failure.
2	Myo	WB/Serum/Plasma	12min.	5-400ng/ml	<58ng/ml	acute myocardial infarction (AMI) in early stage.
3	CK-MB	WB/Serum/Plasma	12min.	1-200ng/ml	<5ng/ml	acute myocardial infarction (AMI) in early stage.
4	NT-proBNP	WB/Serum/Plasma	10min.	20-35000pg/ml	Under 75:0~347pg/mL, Over 75:0~449pg/mL	heart failure .
5	D-Dimer	WB/Plasma	10min.	40-10000ng/ml	<500ng/ml	disseminated intravascular coagulation (DIC),deep vein thrombosis (DVT),pulmonary embolism (PE), myocardial infarction, cerebral infarction, etc.
6	cTnI+Myo+CKMB	WB/Serum/Plasma	12min.	same with single item	same with single item	Triple marker of myocardial infarction.
7	ST2	WB/Serum/Plasma	10min.	10-400ng/ml	<35ng/ml	heart failure .
8	Lp-PLA2	WB/Serum/Plasma	10min.	10-900ng/ml	<175ng/ml	Risk evaluation of ACS and atherosclerotic ischemic stroke patients.
9	S100-β	WB/Serum/Plasma	10min.	0.05-10ng/ml	<0.2ng/ml	Cerebral infarction, cerebral injury.
Inflammation
10	CRP / hs-CRP	WB/Serum/Plasma	3min.	0.5-200mg/L	CRP<10mg/L,hs-CRP<1mg/L	nonspecficity inflammatory marker.
11	SAA	Serum	5min.	1-200mg/L	<10mg/L	inflammation&infection.
12	PCT	WB/Serum/Plasma	10min.	0.2-100ng/ml	<0.5ng/ml	Sepsis
13	CRP+SAA	WB/Serum/Plasma	5min.	same with single item	same with single item	inflammation&infection.
14	IL-6	WB/Serum/Plasma	10min.	5-4000pg/ml	10pg/ml	diabetes,rheumatoid arthritis,etc
Thyroid Hormone
15	TSH	Serum/Plasma	15min.	0.3-100mU/L	0.35-5mU/L	hyperthyroidism and hypothyroidism
16	TT3	Serum/Plasma	15min.	0.5-10nmol/L	1.3-3.1nmol/L	thyroid dysfunction
17	TT4	Serum/Plasma	15min.	5-300nmol/L	66-181nmol/L	thyroid dysfunction
18	FT3	Serum/Plasma	15min.	1-100pmol/L	4-10pmol/L	thyroid dysfunction
19	FT4	Serum/Plasma	15min.	5-300pmol/L	19-39pmol/L	thyroid dysfunction
Tumor Marker
20	AFP	Serum/Plasma	15min.	2.5-200ng/ml	<20ng/ml	pregnancy cancer
21	CEA	Serum/Plasma	15min.	1-200ng/ml	<5ng/ml	colon cancer, colorectal cancer,etc.
22	NSE	Serum/Plasma	15min.	1-400ng/ml	<16ng/ml	non-small cell lung cancer
23	FOB	fecal specimens	10min.	50-1000ng/ml	<100ng/ml	Abnormal recessive gastrointestinal bleeding
24	PG II	Serum/Plasma	15min.	1-100ug/L	PGI/PGII>3.0	gastric abnormalities
25	PG I	Serum/Plasma	15min.	2.5-200ug/L	>70ng/ml	gastric abnormalities
26	TPSA	Serum/Plasma	15min.	0.5-40ng/ml	<4ng/ml	prostate cancer
27	FPSA	Serum/Plasma	15min.	0.1-10ng/ml	<1ng/ml	prostate cancer
28	CA12-5	Serum/Plasma	15min.	20-500U/ml	<35U/ml	ovarian cancer
29	CA15-3	Serum/Plasma	15min.	10-400U/ml	< 25 U/mL	breast cancer
30	HE4	Serum/Plasma	15min.	50-2000pmol/L	<140 pmol/L	ovarian cancer
31	CA19-9	Serum/Plasma	15min.	10-400U/ml	< 27 U/mL	pancreatic cancer
32	β-HCG	Serum/Plasma	15min.	5-400mIU/ml	<10 mIU/mL	Early pregrancy, ectopic HCG cancer,incomplete abortion
33	CK19(Cyfra21-1)	Serum/Plasma	15min.	0.5-50ng/ml	<2.5ng/ml	non-small cell lung cancer
Fertility
34	HCG / β-HCG	Serum/Plasma	10min.	5-20000mIU/ml	<5 mIU/mL	early pregrancy.
35	AMH	Serum/Plasma	10min.	0.1-16ng/ml	Male: 20-60 years old, 0.92-13.89 ng/mL Female: 20-29 years old, 0.88-10.35 ng/mL 30-39 years old, 0.31-7.86 ng/mL 40 -50 years old, <5. 07 ng/mL	ovarian reserve level
Gastrointestinal
36	FOB	fecal specimens	10min.	qualitative	qualitative	gastrointestinal hemorrhage.
37	TRF	fecal specimens	10min.	qualitative	qualitative	gastrointestinal hemorrhage.
38	FOB+TRF	fecal specimens	10min.	qualitative	qualitative	gastrointestinal hemorrhage.
Infection
39	C.Pneumonia	WB/Serum/Plasma	15min.	qualitative	qualitative	CP infection
40	M.Pneumonia	WB/Serum/Plasma	15min.	qualitative	qualitative	MP infection
41	Covid-19 Antigen	nasal swab, throat swab or nasal wash/aspirate specimens	15min.	qualitative	qualitative	respiratory tract
42	Covid-19 Ab IgG/IgM	WB/Serum/Plasma	15min.	qualitative	qualitative	respiratory tract
43	FluA	nasal swab, throat swab or nasal wash/aspirate specimens	15min.	qualitative	qualitative	respiratory tract
44	FluB	nasal swab, throat swab or nasal wash/aspirate specimens	15min.	qualitative	qualitative	respiratory tract
Renal Injury
45	CysC	WB/Serum/Plasma	5min.	0.4-9mg/L	0.5-1.1mg/L	renal function
46	NGAL	Urine	10min.	10-1500ng/mL	<132ng/mL	acute kidney injury.
Other
47	FERR	Serum	5min.	10-500ng/ml	Male:24ng/mL~335ng/mL, Female:11ng/mL~307ng/mL	iron metabolism related diseases, such as hemochromatosis and iron deficiency anemia
48	HbA1c	WB	10min.	4%-14%	4%-6%	diabetes
49	VD	Serum/Plasma	15min.	8-70ng/mL	19-57ng/mL	fetation

Product Tags:


*From:	Your email address is incorrect!
*To:	WWHS Biotech.Inc(exclusive marketed by Dawin)
*Subject:	Subject is empty!
*Message:	For the best results, we recommend including the following details: -Self introduction -Required specifications -Inquire about price/MOQ Characters Remaining: (0/3000) Please enter 20 to 3000 characters to contact this supplier!

Categories	Cardiac Testing Kit
Brand Name:	WWHS
Model Number:	Lp-PLA2
Certification:	CE
Place of Origin:	CN
MOQ:	1000
Price:	Negotiable
Payment Terms:	T/T
Supply Ability:	50000 Kits per Week
Delivery Time:	7 Days
Packaging Details:	Colorful Paper Box
Product Name:	Lp-PLA2 Rapid Test Kit
Diagnosis:	CHD
Package:	25T
Reactivity:	Human
Throughput:	5000 Tests/Day
Usage:	Cardiac Diagnostic
Main Application:	Physical Examination Center
Synonymous:	Lipoprotein Phospholipase A2
Formal Name:	Lipoprotein-associated Phospholipase A2
Application In:	WWHS NIR-1000 Dry Fluoroimmunoassay Analyser